Heterocyclic inhibitors of ATR kinase

The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.

Saved in:
Bibliographic Details
Main Authors LIVELY, Sarah, RAMASWAMY, Suyambu Kesava Vijayan, JONES, Philip, JOHNSON, Michael Garrett, DI FRANCESCO, Maria Emilia, CROSS, Jason Bryant, LAPOINTE, David, CARROLL, Christopher Lawrence
Format Patent
LanguageEnglish
Published 23.03.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.
Bibliography:Application Number: AU20180301696